Tango Therapeutics, Inc. TNGX 深 沪
等待开盘 05-23 09:30:00 美东时间
20.24
-1.380
-6.38%
华盛通- 最 高21.63
- 今 开21.45
- 成交量 165.14万股
- 最 低 20.21
- 昨 收 21.62
- 总市值 29.28亿
- 52周最高 28.41
- 市盈率 静 --
- 换手率 1.14%
- 52周最低 2.1208
- 委 比 62.50%
- 总股本 1.45亿
- 历史最高 28.41
- 量 比 0.46
- 振 幅 6.57%
- 历史最低 1.03
- 每 手 1
- 风险率 6.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
Why Figma Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Figma Inc (NYSE: FIG) shares rose 10.6% in pre-market trading after beating Q1 revenue and earnings estimates and raising FY26 sales guidance.
05-15 17:38
美股大行评级 | 阿里、京东、英伟达、思科等获多家大行上调目标价；Doximity、Dynatrace、Enovix、Wix.com等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Autolus Therapeutics"买入"评级，目标价从9美元升至10美元；Maxim Group：维持Rezolute"买入"评级，目标价从4美元升至10美元
05-15 10:49
Wedbush Maintains Outperform on Tango Therapeutics, Raises Price Target to $33
Wedbush analyst Robert Driscoll maintains Tango Therapeutics (NASDAQ:TNGX) with a Outperform and raises the price target from $19 to $33.
05-14 21:23
美股周涨跌榜 | 净回报超2600%！资管公司潘兴广场上市三日累涨超58%；慧荣科技周涨超52%
累计净回报超2600%！资管公司潘兴广场上市三日累涨超58%；慧荣科技周涨超52%，Q1营收同比翻倍大超预期>>
05-04 18:33
美股大行评级 | 美银大幅上调西部数据、希捷科技目标价！宝洁、Baker Hughes、Flagstar Bank、斯伦贝谢等获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从48美元升至49美元；Chardan Capital：维持Intellia Therapeutics"买入"评级，目标价从27美元升至30美元
04-28 10:07
Stifel Maintains Buy on Tango Therapeutics, Raises Price Target to $40
Stifel analyst Laura Prendergast maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price target from $24 to $40.
04-27 19:31
Tango Therapeutics Appoints Matthew Gall CFO, Effective Immediately
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced key leadership appointments,
04-15 21:16
美股大行评级 | 摩根大通上调霸王茶姬至"超配"，目标价上调至16美元；康尼格拉食品遭高盛、瑞银等7家机构下调目标价
今日重点评级关注：Leerink Partners：维持Camp4 Therapeutics"跑赢大市"评级，目标价从8美元升至9美元；韦德布什：维持Arcus Biosciences"跑赢大市"评级，目标价从37美元升至41美元
04-06 16:27
Canaccord Genuity Initiates Coverage On Tango Therapeutics with Buy Rating, Announces Price Target of $30
Canaccord Genuity analyst John Newman initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Buy rating and announces Price Target of $30.
04-02 22:12
